Konica Minolta Maintains CR Market Leadership in MD Buyline 2013 Surveys

Konica Minolta Maintains CR Market Leadership in MD Buyline 2013 Surveys

Wayne, NJ, January 29, 2014 – Konica Minolta Healthcare Americas announced today that for the eighth year in a row, the company is the top rated CR solutions vendor in the U.S. according to MD Buyline survey results. MD Buyline is a leading, independent provider of evidence-based information and vendor rankings are based on actual user satisfaction composite ratings.

Konica Minolta received the highest ranking across all six categories and was the only company to receive a 9.0 or higher in each of the categories. Additionally, Konica Minolta has been the only company to maintain a composite rating of 9.0 or higher since the first quarter of 2012. In the last two quarters of 2013, Konica Minolta has maintained its 9.0+ rating while the market average of all vendors declined.

“The latest MD Buyline results are further testament to the superiority of Konica Minolta CR solutions customer experience, particularly in the areas of performance, post sale support, and reliability,” says Diane Hunt, Vice President, Marketing, The America’s. “We are very proud to deliver products and services that exceed our customers’ expectations. We and our distribution partners are committed to raising the industry bar for expected level of product features and quality, post sales service and applications training across all of Konica Minolta’s Primary Imaging Solutions.”

In the latest survey, MD Buyline reported that rather than eliminating CR technology, customers are placing their CR units in strategic areas where the use of CR remains an optimal workflow solution. MD Buyline noted that customers continue to use CR technology in conjunction with DR technology. Konica Minolta CR solutions, REGIUS, Nano and ImagePilot CR remain at the top of the list for buyers’ future purchases of CR due to the high uptime levels noted in the MD Buyline survey.

©2014 Konica Minolta Healthcare Americas, Inc.